New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers describe tools to better understand CaMKII, a protein involved in brain and heart disease

Researchers describe tools to better understand CaMKII, a protein involved in brain and heart disease

by CU Anschutz Medical CampusOptogenetic tools for monitoring and controlling CaMKII activation(A) Camui is a FRET-based sensor that detects conformational changes in CaMKII upon activation. An N
Breakthroughs March 30,2024
Researchers describe tools to better understand CaMKII, a protein involved in brain and heart disease

Researchers describe tools to better understand CaMKII, a protein involved in brain and heart disease

by CU Anschutz Medical CampusOptogenetic tools for monitoring and controlling CaMKII activation(A) Camui is a FRET-based sensor that detects conformational changes in CaMKII upon activation. An N
Breakthroughs March 30,2024
Study uses metabolomics to identify novel diagnostic markers for chronic obstructive pulmonary disease

Study uses metabolomics to identify novel diagnostic markers for chronic obstructive pulmonary disease

by Cactus CommunicationsAlterations in metabolism of lipids, amino acids, glucose, nucleotides, and pulmonary and gut microbiome play a crucial role in COPD development. These metabolites have great p
Breakthroughs March 30,2024
Study uses metabolomics to identify novel diagnostic markers for chronic obstructive pulmonary disease

Study uses metabolomics to identify novel diagnostic markers for chronic obstructive pulmonary disease

by Cactus CommunicationsAlterations in metabolism of lipids, amino acids, glucose, nucleotides, and pulmonary and gut microbiome play a crucial role in COPD development. These metabolites have great p
Breakthroughs March 30,2024
Study discovers how a magnesium cellular transport 'pump' plays a vital role in cardiac function

Study discovers how a magnesium cellular transport 'pump' plays a vital role in cardiac function

by Steven Lee,University of Texas Health Science Center at San AntonioCredit:Molecular Cell(2024). DOI: 10.1016/j.molcel.2024.02.033Magnesium is a mineral critical to a wide range of
Breakthroughs March 30,2024
Study discovers how a magnesium cellular transport 'pump' plays a vital role in cardiac function

Study discovers how a magnesium cellular transport 'pump' plays a vital role in cardiac function

by Steven Lee,University of Texas Health Science Center at San AntonioCredit:Molecular Cell(2024). DOI: 10.1016/j.molcel.2024.02.033Magnesium is a mineral critical to a wide range of
Breakthroughs March 30,2024
Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

by Van Andel Research InstituteCredit: Unsplash/CC0 Public DomainA pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers
Breakthroughs March 30,2024
Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

by Van Andel Research InstituteCredit: Unsplash/CC0 Public DomainA pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers
Breakthroughs March 30,2024
Follow-up colonoscopy rate low within six months of abnormal stool test

Follow-up colonoscopy rate low within six months of abnormal stool test

by Elana GotkineFewer than half of adults have a follow-up colonoscopy within six months following an abnormal stool-based screening test (SBT) for colorectal cancer (CRC), according to a study publis
Breakthroughs March 30,2024
Follow-up colonoscopy rate low within six months of abnormal stool test

Follow-up colonoscopy rate low within six months of abnormal stool test

by Elana GotkineFewer than half of adults have a follow-up colonoscopy within six months following an abnormal stool-based screening test (SBT) for colorectal cancer (CRC), according to a study publis
Breakthroughs March 30,2024
Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

by Boston University School of MedicineCasual dose-response curves of FBG, HDL, and adiponectin with annualized memory change. The x-axis represents the values of biomarkers. The y-axis represent
Breakthroughs March 30,2024
Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

by Boston University School of MedicineCasual dose-response curves of FBG, HDL, and adiponectin with annualized memory change. The x-axis represents the values of biomarkers. The y-axis represent
Breakthroughs March 30,2024
Improving the world's most potent cancer drug

Improving the world's most potent cancer drug

by University of Tennessee at KnoxvilleElizabeth Barker. Credit: Shawn Poynter, University of TennesseeFourteen mice scurried around in laboratory cages, eating, sniffing, and running peacefully.
Breakthroughs March 30,2024
Improving the world's most potent cancer drug

Improving the world's most potent cancer drug

by University of Tennessee at KnoxvilleElizabeth Barker. Credit: Shawn Poynter, University of TennesseeFourteen mice scurried around in laboratory cages, eating, sniffing, and running peacefully.
Breakthroughs March 30,2024
Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

by Impact Journals LLCAnalysis of immune cell subsets during neoadjuvant therapy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28567A new research paper was published inOncotarg
Breakthroughs March 30,2024
Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

by Impact Journals LLCAnalysis of immune cell subsets during neoadjuvant therapy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28567A new research paper was published inOncotarg
Breakthroughs March 30,2024
Predicting weight gain in children using second generation anti-psychotic medication

Predicting weight gain in children using second generation anti-psychotic medication

by Laurie Fickman,University of HoustonCredit: CC0 Public DomainA new study from University of Houston College of Pharmacy researchers examined the development and predictors of clinically signi
Breakthroughs March 30,2024
Predicting weight gain in children using second generation anti-psychotic medication

Predicting weight gain in children using second generation anti-psychotic medication

by Laurie Fickman,University of HoustonCredit: CC0 Public DomainA new study from University of Houston College of Pharmacy researchers examined the development and predictors of clinically signi
Breakthroughs March 30,2024
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

by St. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainResistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Chil
Breakthroughs March 30,2024
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

by St. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainResistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Chil
Breakthroughs March 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com